{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:32:18Z","timestamp":1779366738445,"version":"3.53.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"crossref","award":["943698"],"award-info":[{"award-number":["943698"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11033-020-05825-5","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T18:02:27Z","timestamp":1600106547000},"page":"7583-7592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Carnosic acid prevented olanzapine-induced metabolic disorders through AMPK activation"],"prefix":"10.1007","volume":"47","author":[{"given":"Bibi Marjan","family":"Razavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Abazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rameshrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3483-851X","authenticated-orcid":false,"given":"Hossein","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"5825_CR1","unstructured":"WHO (2000) Obesity: preventing and managing the global epidemic Report of a WHO Consultation (WHO Technical Report Series 894)"},{"key":"5825_CR2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/wps.20508","volume":"17","author":"PH Lysaker","year":"2018","unstructured":"Lysaker PH, Pattison ML, Leonhardt BL et al (2018) Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments. World Psychiatr 17:12\u201323","journal-title":"World Psychiatr"},{"key":"5825_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1017\/neu.2019.41","volume":"32","author":"HT Corfitsen","year":"2020","unstructured":"Corfitsen HT, Krantz B, Larsen A et al (2020) Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain. Acta Neuropsychiatr 32:72\u201383","journal-title":"Acta Neuropsychiatr"},{"key":"5825_CR4","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","volume":"156","author":"D Allison","year":"1999","unstructured":"Allison D, Mentore J, Heo M et al (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156:1686\u20131696","journal-title":"Am J Psychiatry"},{"key":"5825_CR5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2006.09.009","volume":"551","author":"BM Patil","year":"2006","unstructured":"Patil BM, Kulkarni NM, Unger BS (2006) Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain. Eur J Pharmacol 551:112\u2013115","journal-title":"Eur J Pharmacol"},{"key":"5825_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1639-8","volume":"207","author":"S Kirk","year":"2009","unstructured":"Kirk S, Glazebrook J, Grayson B et al (2009) Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors. Psychopharmacology 207:119\u2013125","journal-title":"Psychopharmacology"},{"key":"5825_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/JCP.0b013e31819302c3","volume":"29","author":"A Gunes","year":"2009","unstructured":"Gunes A, Melkersson K, Scordo M et al (2009) Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine. J Clin Psychopharmacol 29:65\u201368","journal-title":"J Clin Psychopharmacol"},{"key":"5825_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pbb.2010.05.029","volume":"97","author":"SS Evers","year":"2010","unstructured":"Evers SS, Calcagnoli F, Dijk V et al (2010) Olanzapine causes hypothermia inactivity, a deranged feeding pattern and weight gain in female Wistar rats. Pharmacol Biochem Behav 97:163\u2013169","journal-title":"Pharmacol Biochem Behav"},{"key":"5825_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2010.10.039","volume":"217","author":"K Weston-Greena","year":"2011","unstructured":"Weston-Greena K, Huanga X et al (2011) Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats. Behav Brain Res 217:337\u2013346","journal-title":"Behav Brain Res"},{"key":"5825_CR10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/plants9050651","volume":"9","author":"LM de Macedo","year":"2020","unstructured":"de Macedo LM, Dos Santos EM, Militao L et al (2020) Rosemary (Rosmarinus officinalis L., syn salvia rosmarinus spenn.) and its topical applications: a review. Plants 9:651","journal-title":"Plants"},{"key":"5825_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1872-034X.2010.00747.x","volume":"41","author":"T Wang","year":"2011","unstructured":"Wang T, Takikawa Y, Satoh T et al (2011) Carnosic acid prevents obesity and hepatic steatosis in ob\/ob mice. Hepatol Res 41:87\u201392","journal-title":"Hepatol Res"},{"key":"5825_CR12","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1021\/acs.jafc.5b01246","volume":"63","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Sedighi R, Wang P et al (2015) Carnosic acid as a major bioactive component in rosemary extract ameliorates high-fat-diet-induced obesity and metabolic syndrome in mice. J Agric Food Chem 63:4843\u20134852","journal-title":"J Agric Food Chem"},{"key":"5825_CR13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/mnfr.201300524","volume":"58","author":"M Romo-Vaquero","year":"2014","unstructured":"Romo-Vaquero M, Larrosa M, Yanez-Gascon MJ et al (2014) A rosemary extract enriched in carnosic acid improves circulating adipocytokines and modulates key metabolic sensors in lean Zucker rats: critical and contrasting differences in the obese genotype. Mol Nutr Food Res 58:942\u2013953","journal-title":"Mol Nutr Food Res"},{"key":"5825_CR14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jsfa.6973","volume":"95","author":"MY Park","year":"2015","unstructured":"Park MY, Sung MK (2015) Carnosic acid attenuates obesity-induced glucose intolerance and hepatic fat accumulation by modulating genes of lipid metabolism in C57BL\/6J-ob\/ob mice. J Sci Food Agric 95:828\u2013835","journal-title":"J Sci Food Agric"},{"key":"5825_CR15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40618-014-0150-1","volume":"37","author":"BM Razavi","year":"2014","unstructured":"Razavi BM, Hosseinzadeh H (2014) A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome. J Endocrinol Invest 37:1031\u20131040","journal-title":"J Endocrinol Invest"},{"key":"5825_CR16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.biopha.2017.05.113","volume":"92","author":"BM Razavi","year":"2017","unstructured":"Razavi BM, Lookian F, Hosseinzadeh H (2017) Protective effects of green tea on olanzapine-induced-metabolic syndrome in rats. Biomed Pharmacother 92:726\u2013731","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"5825_CR17","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40618-015-0313-8","volume":"38","author":"A Hosseini","year":"2015","unstructured":"Hosseini A, Hosseinzadeh H (2015) A review on the effects of Allium sativum (Garlic) in metabolic syndrome. J Endocrinol Invest 38(11):1147\u20131157","journal-title":"J Endocrinol Invest"},{"key":"5825_CR18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ptr.5805","volume":"31","author":"J Tabeshpour","year":"2017","unstructured":"Tabeshpour J, Razavi BM, Hosseinzadeh H (2017) Effects of Avocado (Persea americana) on metabolic syndrome: a comprehensive systematic review. Phytother Res 31:819\u2013837","journal-title":"Phytother Res"},{"key":"5825_CR19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00210-016-1256-0","volume":"389","author":"FV Hassani","year":"2016","unstructured":"Hassani FV, Shirani K, Hosseinzadeh H (2016) Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review. Naunyn-Schmiedeberg's Arch Pharmacol 389:931\u2013949","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"5825_CR20","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jsfa.8134","volume":"97","author":"BM Razavi","year":"2017","unstructured":"Razavi BM, Hosseinzadeh H (2017) Saffron: a promising natural medicine in the treatment of metabolic syndrome. J Sci Food Agric 97:1679\u20131685","journal-title":"J Sci Food Agric"},{"issue":"12","key":"5825_CR21","first-page":"1258","volume":"19","author":"H Mollazadeh","year":"2016","unstructured":"Mollazadeh H, Hosseinzadeh H (2016) Cinnamon effects on metabolic syndrome: a review based on its mechanisms. Iran J Basic Med Sci 19(12):1258\u20131270","journal-title":"Iran J Basic Med Sci"},{"key":"5825_CR22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ptr.5570","volume":"30","author":"M Akaberi","year":"2016","unstructured":"Akaberi M, Hosseinzadeh H (2016) Grapes (Vitis vinifera) as a potential candidate for the therapy of the metabolic syndrome. Phytother Res 30:540\u201356","journal-title":"Phytother Res"},{"key":"5825_CR23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40618-014-0096-3","volume":"37","author":"H Hosseinzadeh","year":"2014","unstructured":"Hosseinzadeh H, Nassiri-Asl M (2014) Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid. J Endocrinol Invest 37:783\u2013788","journal-title":"J Endocrinol Invest"},{"key":"5825_CR24","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1172\/JCI67227","volume":"123","author":"NB Ruderman","year":"2013","unstructured":"Ruderman NB, Carling D, Prentki M et al (2013) AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 123:2764\u20132772","journal-title":"J Clin Invest"},{"key":"5825_CR25","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.bmcl.2004.01.091","volume":"14","author":"K Ninomiya","year":"2004","unstructured":"Ninomiya K, Matsuda H, Shimoda H et al (2004) Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorg Med Chem lett 14:1943\u20131946","journal-title":"Bioorg Med Chem lett"},{"key":"5825_CR26","doi-asserted-by":"crossref","first-page":"R1565","DOI":"10.1152\/ajpregu.00759.2001","volume":"282","author":"JN Lorenz","year":"2002","unstructured":"Lorenz JN (2002) A practical guide to evaluating cardiovascular, renal, and pulmonary function in mice. Am J Physiol Regul Integr Comp Physiol 282:R1565\u2013R1582","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5825_CR27","first-page":"121","volume":"152","author":"AA Arjona","year":"2004","unstructured":"Arjona AA, Zhang SX, Adamson B et al (2004) An animal model of antipsychotic-induced weight gain. Behav Brain Res 152:121\u2013127","journal-title":"Behav Brain Res"},{"key":"5825_CR28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14740338.2020.1713091","volume":"19","author":"BB Barton","year":"2020","unstructured":"Barton BB, Segger F, Fischer K et al (2020) Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis. Expert Opin Drug Saf 19:295\u2013314","journal-title":"Expert Opin Drug Saf"},{"key":"5825_CR29","first-page":"1476","volume":"22","author":"S Malekzadeh","year":"2019","unstructured":"Malekzadeh S, Heidari MR, Razavi BM et al (2019) Effect of safranal, a constituent of saffron, on olanzapine (an atypical antipsychotic) induced metabolic disorders in rat. Iran J Basic Med Sci 22:1476\u20131482","journal-title":"Iran J Basic Med Sci"},{"key":"5825_CR30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/026988110201600402","volume":"16","author":"AJ Goudie","year":"2002","unstructured":"Goudie AJ, Smith JA, Halford JC (2002) Characterization of olanzapine-induced weight gain in rats. J Psychopharmacol 16:291\u2013296","journal-title":"J Psychopharmacol"},{"key":"5825_CR31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamapsychiatry.2015.2582","volume":"73","author":"MO Nielsen","year":"2016","unstructured":"Nielsen MO, Rostrup E, Wulff S et al (2016) Striatal reward activity and antipsychotic-associated weight change in patients with schizophrenia undergoing initial treatment. JAMA Psychiatry 73:121\u2013128","journal-title":"JAMA Psychiatry"},{"key":"5825_CR32","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1172\/JCI93362","volume":"127","author":"CC Lord","year":"2017","unstructured":"Lord CC, Wyler SC, Wan R et al (2017) The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. J Clin Invest 127:3402\u20133406","journal-title":"J Clin Invest"},{"key":"5825_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2009.11.009","volume":"34","author":"C Deng","year":"2010","unstructured":"Deng C, Weston-Green K, Huang XF (2010) The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain? Prog Neuro-psychopharmacol biol Psychiatry 34:1\u20134","journal-title":"Prog Neuro-psychopharmacol biol Psychiatry"},{"key":"5825_CR34","doi-asserted-by":"crossref","first-page":"e20571","DOI":"10.1371\/journal.pone.0020571","volume":"6","author":"J Ferno","year":"2011","unstructured":"Ferno J, Varela L, Skrede S et al (2011) Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS ONE 6:e20571","journal-title":"PLoS ONE"},{"key":"5825_CR35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00787-016-0866-x","volume":"26","author":"I Baeza","year":"2017","unstructured":"Baeza I, Vigo L, de la Serna E et al (2017) The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study. Eur child Adoles Psychiatry 26:35\u201346","journal-title":"Eur child Adoles Psychiatry"},{"key":"5825_CR36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.crvi.2005.12.012","volume":"329","author":"G Ailhaud","year":"2006","unstructured":"Ailhaud G (2006) Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. Comptes Rendus Biol 329:570\u2013577","journal-title":"Comptes Rendus Biol"},{"key":"5825_CR37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2010.04.008","volume":"127","author":"R Coccurello","year":"2010","unstructured":"Coccurello R, Moles A (2010) Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design. Pharmacol Ther 127:210\u2013251","journal-title":"Pharmacol Ther"},{"key":"5825_CR38","doi-asserted-by":"crossref","first-page":"E250","DOI":"10.1152\/ajpendo.00315.2017","volume":"315","author":"MR Rickels","year":"2018","unstructured":"Rickels MR, Perez EM, Peleckis AJ et al (2018) Contribution of parasympathetic muscarinic augmentation of insulin secretion to olanzapine-induced hyperinsulinemia. Am J Physiol Endocrinol Met 315:E250\u2013E257","journal-title":"Am J Physiol Endocrinol Met"},{"key":"5825_CR39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.appet.2006.01.008","volume":"46","author":"J Minet-Ringuet","year":"2006","unstructured":"Minet-Ringuet J, Even PC, Goubern M et al (2006) Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration. Appetite 46:254\u2013262","journal-title":"Appetite"},{"key":"5825_CR40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00004714-200208000-00015","volume":"22","author":"P Monteleone","year":"2002","unstructured":"Monteleone P, Fabrazzo M, Tortorella A et al (2002) Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment. J Clin Psychopharmacol 22:424\u2013426","journal-title":"J Clin Psychopharmacol"},{"key":"5825_CR41","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2337\/diabetes.54.3.862","volume":"54","author":"M Ader","year":"2005","unstructured":"Ader M, Kim SP, Catalano KJ et al (2005) Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease a placebo-controlled study of olanzapine and risperidone in dogs. Diabetes 54:862","journal-title":"Diabetes"},{"key":"5825_CR42","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.4088\/JCP.v68n1113","volume":"68","author":"R Perez-Iglesias","year":"2007","unstructured":"Perez-Iglesias R, Crespo-Facorro B, Amado JA et al (2007) A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone. J Clin Psychiatry 68:1733\u20131740","journal-title":"J Clin Psychiatry"},{"key":"5825_CR43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0269881105056647","volume":"20","author":"H Hosojima","year":"2006","unstructured":"Hosojima H, Togo T, Odawara T et al (2006) Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia. J Psychopharmacol 20:75\u201379","journal-title":"J Psychopharmacol"},{"key":"5825_CR44","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1017\/S0007114511001620","volume":"106","author":"A Ibarra","year":"2011","unstructured":"Ibarra A, Cases J, Roller M et al (2011) Carnosic acid-rich rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and improves cholesterol levels and glycaemia in mice on a high-fat diet. Br J Nutr 106:1182\u20131189","journal-title":"Br J Nutr"},{"key":"5825_CR45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tcm.2005.04.005","volume":"15","author":"LH Young","year":"2005","unstructured":"Young LH, Li J, Baron SJ et al (2005) AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med 15:110\u2013118","journal-title":"Trends Cardiovasc Med"},{"key":"5825_CR46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1113\/jphysiol.2006.109389","volume":"574","author":"JRB Dyck","year":"2006","unstructured":"Dyck JRB (2006) AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol 574:95\u2013112","journal-title":"J Physiol"},{"key":"5825_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2754078","author":"MK Huynh","year":"2016","unstructured":"Huynh MK, Kinyua AW, Yang DJ et al (2016) Hypothalamic AMPK as a regulator of energy homeostasis. Neural Plast. https:\/\/doi.org\/10.1155\/2016\/2754078","journal-title":"Neural Plast"},{"key":"5825_CR48","doi-asserted-by":"crossref","first-page":"e93310","DOI":"10.1371\/journal.pone.0093310","volume":"9","author":"Y Hu","year":"2014","unstructured":"Hu Y, Young AJ, Ehli EA et al (2014) Metformin and berberine prevent olanzapine-induced weight gain in rats. PLoS ONE 9:e93310","journal-title":"PLoS ONE"},{"key":"5825_CR49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00535-012-0546-7","volume":"47","author":"T Wang","year":"2012","unstructured":"Wang T, Takikawa Y, Tabuchi T et al (2012) Carnosic acid (CA) prevents lipid accumulation in hepatocytes through the EGFR\/MAPK pathway. J Gastroenterol 47:805\u2013813","journal-title":"J Gastroenterol"},{"key":"5825_CR50","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/jpet.118.248393","volume":"365","author":"ND Bush","year":"2018","unstructured":"Bush ND, Townsend LK, Wright DC (2018) AICAR prevents acute olanzapine-induced disturbances in glucose homeostasis. J Pharmacol Exp Ther 365:526\u2013535","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"5825_CR51","doi-asserted-by":"crossref","first-page":"fj.201901820R","DOI":"10.1096\/fj.201901820R","volume":"33","author":"H Shamshoum","year":"2019","unstructured":"Shamshoum H, Medak KD, Townsend LK et al (2019) AMPK \u03b21 activation suppresses antipsychotic-induced hyperglycemia in mice. FASEB J 33(12):fj.201901820R","journal-title":"FASEB J"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05825-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05825-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05825-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T06:42:30Z","timestamp":1668753750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05825-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["5825"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05825-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"20 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}